Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -94.12% is 52% above its 5-year average of -194.79%, near the high end of its 5-year range (-4281.14%–100.00%).
66.60% above its 12-month average of -281.82%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
-94.12%
GROSS MARGIN AVG TTM
-281.82%
GROSS MARGIN AVG 3Y
-450.15%
GROSS MARGIN AVG 5Y
-194.79%
GROSS MARGIN AVG 10Y
-518.12%
GROSS MARGIN AVG 15Y
-486.37%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+66.60%
CURRENT VS 3Y AVG
+79.09%
CURRENT VS 5Y AVG
+51.68%
CURRENT VS 10Y AVG
+81.83%
CURRENT VS 15Y AVG
+80.65%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
-330.57%
vs the sector median at left
Fate Therapeutics, Inc.
Market Cap
$272.17M
Gross Margin
-94.12%
TTM Avg
-281.82%
3Y Avg
-450.15%
5Y Avg
-194.79%
Market Cap
$270.25M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$270.01M
Gross Margin
92.82%
TTM Avg
94.13%
3Y Avg
92.76%
5Y Avg
92.02%
Market Cap
$269.87M
Gross Margin
79.45%
TTM Avg
80.09%
3Y Avg
80.50%
5Y Avg
80.39%
Market Cap
$269.77M
Gross Margin
0.00%
TTM Avg
-131.21%
3Y Avg
-60.86%
5Y Avg
-7.69%
Market Cap
$266.62M
Gross Margin
85.79%
TTM Avg
85.31%
3Y Avg
84.59%
5Y Avg
70.69%
Market Cap
$263.68M
Gross Margin
93.41%
TTM Avg
92.41%
3Y Avg
88.66%
5Y Avg
85.93%
Market Cap
$262.90M
Gross Margin
41.38%
TTM Avg
41.46%
3Y Avg
41.37%
5Y Avg
45.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $272.17M | -94.12% | -281.82% | -450.15% | -194.79% |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $270.01M | 92.82% | 94.13% | 92.76% | 92.02% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $269.87M | 79.45% | 80.09% | 80.50% | 80.39% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $269.77M | 0.00% | -131.21% | -60.86% | -7.69% |
| Scribe Therapeutics Inc. (SCTX)vs › | $267.00M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $266.62M | 85.79% | 85.31% | 84.59% | 70.69% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | 93.41% | 92.41% | 88.66% | 85.93% |
| OraSure Technologies, Inc. (OSUR)vs › | $262.90M | 41.38% | 41.46% | 41.37% | 45.85% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.92M | 0.00% | 0.00% | -1258.31% | -887.92% |
Gross Margin
-94.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | -124.63% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | -1384.09% |
| 2025-06-30 | -100.37% |
| 2025-03-31 | -1688.58% |
| 2024-12-31 | -821.45% |
| 2024-09-30 | -1027.20% |
| 2024-06-30 | 30.29% |
| 2024-03-31 | -150.44% |
| 2023-12-31 | -191.47% |
| 2023-09-30 | -143.83% |
| 2023-06-30 | -4281.14% |
| 2023-03-31 | -11.27% |
| 2022-12-31 | -96.57% |
| 2022-09-30 | -432.79% |
| 2022-06-30 | -338.34% |
| 2022-03-31 | -291.76% |
| 2021-12-31 | -307.26% |
| 2021-09-30 | -273.50% |
| 2021-06-30 | -258.06% |
| 2021-03-31 | -302.55% |
| 2020-12-31 | -145.23% |
| 2020-09-30 | -306.11% |
| 2020-06-30 | -388.00% |
| 2020-03-31 | -1064.14% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | -855.21% |
| 2019-06-30 | -667.87% |
| 2019-03-31 | -573.56% |
| 2018-12-31 | -748.59% |
| 2018-09-30 | -1229.14% |
| 2018-06-30 | -1537.39% |
| 2018-03-31 | -1018.52% |
| 2017-12-31 | -862.71% |
| 2017-09-30 | -736.06% |
| 2017-06-30 | -672.61% |
| 2017-03-31 | -675.66% |
| 2016-12-31 | -506.62% |
| 2016-09-30 | -563.16% |
| 2016-06-30 | -560.37% |
| 2016-03-31 | -401.97% |
| 2015-12-31 | -404.93% |
| 2015-09-30 | -387.62% |
| 2015-06-30 | -1376.29% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 412.15% |
| 2013-09-30 | -1516.27% |
| 2013-06-30 | -957.59% |
| 2013-03-31 | -436.23% |
| 2012-12-31 | -429.24% |
| 2012-09-30 | -527.84% |
